Showing results (241-250 of 324) with videos related to

Sort By:
Pageof 33
Biomaterials|January 28, 2014
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesiclesYvonne Klapper, Osama A Hamad, Yuji Teramura, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2025
Drug transporter - enzyme crossroads: Does OATP2B1 shape Cyp3a-driven midazolam metabolism in rats?Nikolaos Paloumpis, Marta Rysz, Noemi Bianchi, et al.
Nature Communications|September 20, 2022
Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitorsChristina Lamers, Xiaoguang Xue, Martin Smieško, et al.
Journal of Thrombosis and Haemostasis : JTH|August 23, 2022
Minimal role for the alternative pathway in complement activation by HIT immune complexesAyiesha P Barnes, Sanjay Khandelwal, Simone Sartoretto, et al.
British Journal of Haematology|May 30, 2021
Alpha-defensins: risk factor for thrombosis in COVID-19 infectionSuhair Abdeen, Khalil Bdeir, Rami Abu-Fanne, et al.
Angewandte Chemie (International Ed. in English)|November 10, 2023
Tetra- and Hexavalent Siglec-8 Ligands Modulate Immune Cell ActivationGabriele Conti, Anne Bärenwaldt, Said Rabbani, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 22, 2024
Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in rSlco2b1-Knockout and SLCO2B1-Knockin RatsJonny Kinzi, Janine Hussner, Isabell Seibert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Complement deficiency promotes cutaneous wound healing in miceStavros Rafail, Ioannis Kourtzelis, Periklis G Foukas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2015
Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activityGeorgia Sfyroera, Daniel Ricklin, Edimara S Reis, et al.
Pageof 33